港股異動｜先聲藥業升6.2% 上半年歸母淨利潤暴增超24倍

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

港股異動｜先聲藥業升6.2% 上半年歸母淨利潤暴增超24倍

格隆匯 08-23 10:01

先聲藥業升6.2%，報6.68港元，總市值約178億港元。先聲藥業發佈中期業績，營收33.79億元，同比增長25.2%；歸母淨利潤22.75億元，同比暴增3466.17%。其中，創新藥業務收入24.13億元，佔總營收71.4%，同比增長36.6%，創新藥收入佔比再創新高。

先聲藥業(02096.HK)

Relevant Stocks

先聲藥業(02096.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

港股異動｜先聲藥業升6.2% 上半年歸母淨利潤暴增超24倍

Services

About Us

Agreement Statement